Dharma Biomedical
R & D
Mission Statement
Laboratory Services
R & D Activities
Management Team
Selected Bibliography
Contact Us

Amooranin, a  patent-pending anti-cancer drug derived from Amoora rohituka

New Orleans Saints The Game Tri-Blend T-Shirt - Ash,Men's Cleveland Browns G-III Sports by Carl Banks Brown Powerhouse Twill Jacket Matthew Stafford Jerseys Sale Calvin Johnson Jerseys Sale .New York Giants Woodrow Guitar Guitar Strap,Mens San Francisco 49ers Scarlet Fleece Crew Sweatshirt,Miami Dolphins Carbon Fiber License Plate Barry Sanders Jerseys Sale Cincinnati Bengals Jerseys Wholesale
Summary of claims: Amooranin (AMR) is a novel pentacyclic triterpenoid that has been found to cause tumor cell death through G2/M cell cycle arrest, caspase activation, and apoptosis and is a substrate for P-glycoprotein.  Consequently AMR compounds can be used in the treatment of diseases where aberrant cellular proliferation occurs; drug-sensitive and drug-resistant cancers, autoimmune disorders, and inflammatory diseases.

Rabi T, Ramachandran C, Fonseca HB, Alamo A, Escalon E , Melnick SJ. Amooranin, a novel chemotherapeutic drug induces apoptosis through caspase activity in human breast carcinoma cell lines. Breast Cancer Research and Treatment. 2003;80:321-30.


Ramachandran C, Rabi T, Fonseca HB, Melnick SJ,  Escalon E. Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines. Int. J. Cancer. 2003;105:784-9.


Ramachandran C, Nair PKR, Alamo, A, Cochrane CB, Escalon E, Melnick, SJ. Anticancer Effects of Amooranin in Human Colon Carcinoma Cell Line in vitro and in Nude Mice Xenografts. Int  J Cancer. 2007;119:2443-54.